Life Expectancy in Pancreatic Neuroendocrine Cancer
Published in Clinics and Research in Hepatology and Gastroenterology, 2019
Recommended citation: J Brooks, R Shavelle, K Vavra-Musser, et al. (2019). "Life Expectancy in Pancreatic Neuroendocrine Cancer." Clinics and Research in Hepatology and Gastroenterology. 43(1):88-97. https://www.sciencedirect.com/science/article/abs/pii/S2210740118301517
Life expectancies of patients with PNETs may be markedly reduced from normal, but even in the worst cases their prognoses remain significantly better than that of patients with the more common pancreatic adenocarcinomas. In some very favorable cases, the life expectancy is near-normal, especially amongst 1- and 5-year survivors. This information can be used to counsel patients.
Recommended citation: J Brooks, R Shavelle, K Vavra-Musser, et al. (2019). “Life Expectancy in Pancreatic Neuroendocrine Cancer.” Clinics and Research in Hepatology and Gastroenterology. 43(1):88-97.